Vitality Watch

Dossier clinicaltrials trial late 09-nov-2026
Large or late-phase randomized human trial

Cognitive Level Enhancement Through Vision Exams and Refraction

Key claim: The CLEVER trial investigates whether providing free refractive correction (near and distance glasses) can slow 3-year cognitive decline, reduce falls, and improve quality of life in older adults in India.

Abstract

The investigators aim to conduct a mixed-method study in which a randomised controlled trial (RCT) and a descriptive qualitative study will be conducted. The RCT aims to determine whether free near and distance glasses provided to residents in Hyderabad, India, aged ≥ 60 years, with under- or un- corrected refractive error and normal baseline hearing and cognition (HMSE > 18), can improve quality of life, reduce falls, reduce depression, improve social interaction and physical activity cost-effectively over 36 months. The primary qualitative research aim is to a) contextualize the RCT with information on the milieu and culture in which the trial will be conducted; b) provide data on the lived experiences of older adults with reduced vision in the study area, and c) conduct a process evaluation of the trial.

The primary outcome measure is the three-year change in cognition measured by LASI- DAD (Longitudinal Aging Study in India(LASI)- Diagnostic Assessment of Dementia(DAD) global cognitive score.

Secondary Outcome Measures: Three year change in Quality of Life score measured by WHO QOL-BREF; Visual functioning from the RASCH-scaled version of INDVFQ(Indian Visual Functioning(INDVFQ);self-reported physical activity score measured using IPAQ questionnaire; PHQ9 score; domain specific cognitive score (orientation, executive function, language/fluency, memory) measured by HMSE; Total cost of care including direct and indirect costs; Quality adjusted life years; Incremental Cost Effectiveness Ratio; Number of falls measured by Quick Screen score over the three years; Social network density at 3 years (SNI 1-3 represents a “limited” social network, 4-5 is a “medium” social network, and SNI ≥6 is a “diverse” social network) measured by the SNI score; An additional secondary outcome will be LASI-DAD global cognitive score analysed by excluding any tests determined pre-hoc to depend on visual acuity.

Why this matters

[human-rct] CLEVER moves refractive correction into a planned three-year randomized test of cognitive decline, falls, and quality of life rather than an acute-marker study, but the protocol supplies no evidence of benefit yet. [human-observational] Existing sensory impairment–dementia associations remain vulnerable to confounding and reverse causation; [human-rct] this protocol does not establish dementia prevention or a social-connection-mediated effect.

Source

Link

Briefing card

Cognitive Level Enhancement Through Vision Exams and Refraction
Stage: trial late · clinicaltrials · 09-nov-2026

The CLEVER trial investigates whether providing free refractive correction (near and distance glasses) can slow 3-year cognitive decline, reduce falls, and improve quality of life in older adults in India.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT05458323

build build 880 · 2bcef25 · 2026-11-18